Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Immune responsiveness in a mouse model of combined adoptive immunotherapy with NK and dendritic cells.

Cui F, Ji J, Lv H, Qu D, Yu C, Yang Y, Xu Y.

J Cancer Res Ther. 2013 Nov;9 Suppl:S162-8. doi: 10.4103/0973-1482.122516.

PMID:
24516054
[PubMed - in process]
Free Article
2.

Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.

Hokland M, Kjaergaard J, Kuppen PJ, Nannmark U, Agger R, Hokland P, Basse P.

In Vivo. 1999 May-Jun;13(3):199-204.

PMID:
10459491
[PubMed - indexed for MEDLINE]
3.

Immunotherapy with dendritic cells pulsed with tumor-derived gp96 against murine lung cancer is effective through immune response of CD8+ cytotoxic T lymphocytes and natural killer cells.

Shinagawa N, Yamazaki K, Tamura Y, Imai A, Kikuchi E, Yokouchi H, Hommura F, Oizumi S, Nishimura M.

Cancer Immunol Immunother. 2008 Feb;57(2):165-74. Epub 2007 Jul 13.

PMID:
17628800
[PubMed - indexed for MEDLINE]
4.

Natural killer-dendritic cell cross-talk in cancer immunotherapy.

Kalinski P, Mailliard RB, Giermasz A, Zeh HJ, Basse P, Bartlett DL, Kirkwood JM, Lotze MT, Herberman RB.

Expert Opin Biol Ther. 2005 Oct;5(10):1303-15. Review.

PMID:
16197336
[PubMed - indexed for MEDLINE]
5.
6.

The infiltration of experimentally induced lung metastases of colon carcinoma CC531 by adoptively transferred interleukin-2-activated natural killer cells in Wag rats.

Kuppen PJ, Basse PH, Goldfarb RH, Van De Velde CJ, Fleuren GJ, Eggermont AM.

Int J Cancer. 1994 Feb 15;56(4):574-9.

PMID:
8112894
[PubMed - indexed for MEDLINE]
7.

Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.

Kuhn S, Hyde EJ, Yang J, Rich FJ, Harper JL, Kirman JR, Ronchese F.

J Immunol. 2013 Aug 15;191(4):1984-92. doi: 10.4049/jimmunol.1301135. Epub 2013 Jul 15.

PMID:
23858033
[PubMed - indexed for MEDLINE]
8.

Tumor blood supply and tumor localization by adoptively transferred IL-2 activated natural killer cells.

Nannmark U, Hokland ME, Agger R, Christiansen M, Kjaergaard J, Goldfarb RH, Bagge U, Unger M, Johansson BR, Albertsson PA, Basse PH.

In Vivo. 2000 Sep-Oct;14(5):651-8.

PMID:
11125549
[PubMed - indexed for MEDLINE]
9.

Impaired dendritic cell functions because of depletion of natural killer cells disrupt antigen-specific immune responses in mice: restoration of adaptive immunity in natural killer-depleted mice by antigen-pulsed dendritic cell.

Yoshida O, Akbar F, Miyake T, Abe M, Matsuura B, Hiasa Y, Onji M.

Clin Exp Immunol. 2008 Apr;152(1):174-81. doi: 10.1111/j.1365-2249.2008.03601.x. Epub 2008 Feb 25.

PMID:
18307521
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Microvessel origin and distribution in pulmonary metastases of B16 melanoma: implication for adoptive immunotherapy.

Nannmark U, Johansson BR, Bryant JL, Unger ML, Hokland ME, Goldfarb RH, Basse PH.

Cancer Res. 1995 Oct 15;55(20):4627-32.

PMID:
7553640
[PubMed - indexed for MEDLINE]
Free Article
11.

Enhanced anti-metastatic efficacy of IL-2 activated NK (A-NK) cells with novel benzothiazoles.

Goldfarb RH, Kitson RP, Brunson KW, Yoshino K, Hirota N, Kirii Y, Kotera Y, Inoue Y, Ohashi M.

Anticancer Res. 1999 May-Jun;19(3A):1663-7.

PMID:
10470098
[PubMed - indexed for MEDLINE]
12.

Divergent roles for CD4+ T cells in the priming and effector/memory phases of adoptive immunotherapy.

Hu HM, Winter H, Urba WJ, Fox BA.

J Immunol. 2000 Oct 15;165(8):4246-53.

PMID:
11035058
[PubMed - indexed for MEDLINE]
Free Article
13.

Morphological appearance, content of extracellular matrix and vascular density of lung metastases predicts permissiveness to infiltration by adoptively transferred natural killer and T cells.

Yang Q, Goding S, Hagenaars M, Carlos T, Albertsson P, Kuppen P, Nannmark U, Hokland ME, Basse PH.

Cancer Immunol Immunother. 2006 Jun;55(6):699-707. Epub 2005 Jul 27.

PMID:
16047144
[PubMed - indexed for MEDLINE]
14.

Elimination of established liver metastases by human interleukin 2-activated natural killer cells after locoregional or systemic adoptive transfer.

Okada K, Nannmark U, Vujanovic NL, Watkins S, Basse P, Herberman RB, Whiteside TL.

Cancer Res. 1996 Apr 1;56(7):1599-608.

PMID:
8603408
[PubMed - indexed for MEDLINE]
Free Article
15.

Biodistribution and tumor localization of lymphokine-activated killer T cells following different routes of administration into tumor-bearing animals.

Kjaergaard J, Hokland ME, Agger R, Skovbo A, Nannmark U, Basse PH.

Cancer Immunol Immunother. 2000 Jan;48(10):550-60.

PMID:
10630307
[PubMed - indexed for MEDLINE]
16.

IL-15 and type I interferon are required for activation of tumoricidal NK cells by virus-infected dendritic cells.

Boudreau JE, Stephenson KB, Wang F, Ashkar AA, Mossman KL, Lenz LL, Rosenthal KL, Bramson JL, Lichty BD, Wan Y.

Cancer Res. 2011 Apr 1;71(7):2497-506. doi: 10.1158/0008-5472.CAN-10-3025. Epub 2011 Feb 9.

PMID:
21307131
[PubMed - indexed for MEDLINE]
Free Article
17.

Local administration of IL-12-transfected dendritic cells induces antitumor immune responses to colon adenocarcinoma in the liver in mice.

Satoh Y, Esche C, Gambotto A, Shurin GV, Yurkovetsky ZR, Robbins PD, Watkins SC, Todo S, Herberman RB, Lotze MT, Shurin MR.

J Exp Ther Oncol. 2002 Nov-Dec;2(6):337-49.

PMID:
12440225
[PubMed - indexed for MEDLINE]
18.

Dendritic cell internalization of α-galactosylceramide from CD8 T cells induces potent antitumor CD8 T-cell responses.

Choi DH, Kim KS, Yang SH, Chung DH, Song B, Sprent J, Cho JH, Sung YC.

Cancer Res. 2011 Dec 15;71(24):7442-51. doi: 10.1158/0008-5472.CAN-11-1459. Epub 2011 Oct 25.

PMID:
22028323
[PubMed - indexed for MEDLINE]
Free Article
19.

Optimal culture conditions for the generation of natural killer cell-induced dendritic cells for cancer immunotherapy.

Nguyen-Pham TN, Yang DH, Nguyen TA, Lim MS, Hong CY, Kim MH, Lee HJ, Lee YK, Cho D, Bae SY, Ahn JS, Kim YK, Chung IJ, Kim HJ, Lee JJ.

Cell Mol Immunol. 2012 Jan;9(1):45-53. doi: 10.1038/cmi.2011.23. Epub 2011 Aug 8.

PMID:
21822297
[PubMed - indexed for MEDLINE]
20.

The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.

Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H.

Int J Oncol. 2006 Apr;28(4):947-53.

PMID:
16525645
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk